Literature DB >> 33900583

Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.

Naoko Mori1,2, Hiroyuki Abe3, Shunji Mugikura4,5, Minoru Miyashita6, Yu Mori7, Yo Oguma8, Minami Hirasawa4, Satoko Sato9, Kei Takase4.   

Abstract

PURPOSE: To investigate effective model composed of features from ultrafast dynamic contrast-enhanced magnetic resonance imaging (UF-MRI) for distinguishing low- from non-low-grade ductal carcinoma in situ (DCIS) lesions or DCIS lesions upgraded to invasive carcinoma (upgrade DCIS lesions) among lesions diagnosed as DCIS on pre-operative biopsy.
MATERIALS AND METHODS: Eighty-six consecutive women with 86 DCIS lesions diagnosed by biopsy underwent UF-MRI including pre- and 18 post-contrast ultrafast scans (temporal resolution of 3 s/phase). The last phase of UF-MRI was used to perform 3D segmentation. The time point at 6 s after the aorta started to enhance was used to obtain subtracted images. From the 3D segmentation and subtracted images, enhancement, shape, and texture features were calculated and compared between low- and non-low-grade or upgrade DCIS lesions using univariate analysis. Feature selection by least absolute shrinkage and selection operator (LASSO) algorithm and k-fold cross-validation were performed to evaluate the diagnostic performance.
RESULTS: Surgical specimens revealed 16 low-grade DCIS lesions, 37 non-low-grade lesions and 33 upgrade DCIS lesions. In univariate analysis, five shape and seven texture features were significantly different between low- and non-low-grade lesions or upgrade DCIS lesions, whereas enhancement features were not. The six features including surface/volume ratio, irregularity, diff variance, uniformity, sum average, and variance were selected using LASSO algorism and the mean area under the receiver operating characteristic curve for training and validation folds were 0.88 and 0.88, respectively.
CONCLUSION: The model with shape and texture features of UF-MRI could effectively distinguish low- from non-low-grade or upgrade DCIS lesions.
© 2021. The Japanese Breast Cancer Society.

Entities:  

Keywords:  Breast cancer; Carcinoma; Intraductal; Magnetic resonance imaging; Non-infiltrating

Mesh:

Year:  2021        PMID: 33900583     DOI: 10.1007/s12282-021-01257-6

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  44 in total

Review 1.  Ductal carcinoma in situ of the breast.

Authors:  M J Silverstein
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

Review 2.  Dynamic image interpretation of MRI of the breast.

Authors:  C K Kuhl; H H Schild
Journal:  J Magn Reson Imaging       Date:  2000-12       Impact factor: 4.813

3.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

4.  Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.

Authors:  Donald L Weaver; Robert D Rosenberg; William E Barlow; Laura Ichikawa; Patricia A Carney; Karla Kerlikowske; Diana S M Buist; Berta M Geller; Charles R Key; Susan J Maygarden; Rachel Ballard-Barbash
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

5.  Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 6.  Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

Authors:  Shi-Yi Wang; Tatyana Shamliyan; Beth A Virnig; Robert Kane
Journal:  Breast Cancer Res Treat       Date:  2011-02-15       Impact factor: 4.872

7.  Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.

Authors:  Anthony J Maxwell; Karen Clements; Bridget Hilton; David J Dodwell; Andrew Evans; Olive Kearins; Sarah E Pinder; Jeremy Thomas; Matthew G Wallis; Alastair M Thompson
Journal:  Eur J Surg Oncol       Date:  2018-01-11       Impact factor: 4.424

8.  Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?

Authors:  Tawakalitu O Oseni; Barbara L Smith; Constance D Lehman; Charmi A Vijapura; Niveditha Pinnamaneni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-05-16       Impact factor: 5.344

9.  Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up.

Authors:  Melinda E Sanders; Peggy A Schuyler; Jean F Simpson; David L Page; William D Dupont
Journal:  Mod Pathol       Date:  2014-12-12       Impact factor: 7.842

Review 10.  Grading Ductal Carcinoma In Situ (DCIS) of the Breast - What's Wrong with It?

Authors:  Gábor Cserni; Anita Sejben
Journal:  Pathol Oncol Res       Date:  2019-11-27       Impact factor: 3.201

View more
  3 in total

1.  Principal component analysis of texture features for grading of meningioma: not effective from the peritumoral area but effective from the tumor area.

Authors:  Teiji Tominaga; Kei Takase; Naoko Mori; Shunji Mugikura; Toshiki Endo; Hidenori Endo; Yo Oguma; Li Li; Akira Ito; Mika Watanabe; Masayuki Kanamori
Journal:  Neuroradiology       Date:  2022-08-31       Impact factor: 2.995

2.  Prediction of placenta accreta spectrum using texture analysis on coronal and sagittal T2-weighted imaging.

Authors:  Hainan Ren; Naoko Mori; Shunji Mugikura; Hiroaki Shimizu; Sakiko Kageyama; Masatoshi Saito; Kei Takase
Journal:  Abdom Radiol (NY)       Date:  2021-07-30

Review 3.  Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?

Authors:  Masako Kataoka; Maya Honda; Akane Ohashi; Ken Yamaguchi; Naoko Mori; Mariko Goto; Tomoyuki Fujioka; Mio Mori; Yutaka Kato; Hiroko Satake; Mami Iima; Kazunori Kubota
Journal:  Magn Reson Med Sci       Date:  2022-02-25       Impact factor: 2.760

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.